カテゴリー： Market Monitor Global, 世界, 医療/バイオ

インスリン様成長因子IIの世界市場見通し2023年-2029年

◆英語タイトル：Insulin Like Growth Factor II Market, Global Outlook and Forecast 2023-2029

Market Monitor Globalが発行した調査報告書（MMG23LY8818）◆商品コード：MMG23LY8818
◆発行会社（リサーチ会社）：Market Monitor Global
◆発行日：2023年7月
◆ページ数：70
◆レポート形式：英語 / PDF
◆納品方法：Eメール（受注後2-3営業日）
◆調査対象地域：グローバル
◆産業分野：医薬品＆ヘルスケア
◆販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,250 ⇒換算￥494,000見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD4,225 ⇒換算￥642,200見積依頼/購入/質問フォーム
Enterprise User（閲覧人数制限なし）USD4,875 ⇒換算￥741,000見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いに変更可）
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。

❖ レポートの概要 ❖

Global Insulin Like Growth Factor II Market 調査レポートは次の情報を含め、グローバルにおけるのインスリン様成長因子II市場規模と予測を収録しています。・世界のインスリン様成長因子II市場：売上、2018年-2023年、2024年-2029年
・世界のインスリン様成長因子II市場：販売量、2018年-2023年、2024年-2029年
・世界のトップ5企業、2022年

世界のインスリン様成長因子II市場は2022年に000Mドルと評価され、予測期間中に000％のCAGRで2029年までに000Mドルに達すると予測されています。アメリカ市場は2022年に000Mドルと推定されており、中国は2029年までに000Mドルに達すると予測されています。「デュシギツマブ」セグメントは今後6年間、000%の年平均成長率で2029年までに000Mドルに成長すると予測されています。

インスリン様成長因子IIのグローバル主要企業は、Boehringer Ingelheim GmbH、 Genervon Biopharmaceuticals LLC、 MedImmune LLCなどです。2022年にトップ5企業がグローバル売上シェアの約000%を占めています。

マーケットモニターグローバル社は、インスリン様成長因子IIのメーカー、サプライヤー、流通業者、および業界の専門家を調査しました。これには、販売量、売上、需要、価格変動、製品タイプ、最近の動向と計画、産業トレンド、成長要因、課題、阻害要因、潜在的なリスクなどが含まれます。

【セグメント別マーケット分析】

世界のインスリン様成長因子II市場：タイプ別、2018年-2023年、2024年-2029年
世界のインスリン様成長因子II市場：タイプ別市場シェア、2022年
・デュシギツマブ、M-630、GM-6、M-610.27、ゼンツズマブ、その他

世界のインスリン様成長因子II市場：用途別、2018年-2023年、2024年-2029年
世界のインスリン様成長因子II市場：用途別市場シェア、2022年
・乳がん、ホルモン感受性乳がん、ハンチントン病、筋ジストロフィー、その他

世界のインスリン様成長因子II市場：地域・国別、2018年-2023年、2024年-2029年
世界のインスリン様成長因子II市場：地域別市場シェア、2022年
・北米：アメリカ、カナダ、メキシコ
・ヨーロッパ：ドイツ、フランス、イギリス、イタリア、ロシア
・アジア：中国、日本、韓国、東南アジア、インド
・南米：ブラジル、アルゼンチン
・中東・アフリカ：トルコ、イスラエル、サウジアラビア、UAE

【競争分析】

また、当レポートは主要な参入企業の分析を提供します。
・主要企業におけるインスリン様成長因子IIのグローバル売上、2018年-2023年
・主要企業におけるインスリン様成長因子IIのグローバル売上シェア、2022年
・主要企業におけるインスリン様成長因子IIのグローバル販売量、2018年-2023年
・主要企業におけるインスリン様成長因子IIのグローバル販売量シェア、2022年

さらに、当レポートは主要企業の情報を提示します。
Boehringer Ingelheim GmbH、 Genervon Biopharmaceuticals LLC、 MedImmune LLC

*************************************************************

・調査・分析レポートの概要
インスリン様成長因子II市場の定義
市場セグメント
世界のインスリン様成長因子II市場概要
当レポートの特徴・ベネフィット
調査手法と情報源

・世界のインスリン様成長因子II市場規模
世界のインスリン様成長因子II市場規模：2022年 VS 2029年
世界のインスリン様成長因子II市場規模と予測 2018年-2029年

・競争状況
グローバルトップ企業
売上ベースでのグローバルトップ企業
企業別グローバルでのインスリン様成長因子IIの売上
グローバルトップ3およびトップ5企業、2022年売上ベース
グローバル企業のインスリン様成長因子II製品タイプ
グローバルにおけるティア1、ティア2、ティア3企業

・タイプ別市場分析
タイプ区分：デュシギツマブ、M-630、GM-6、M-610.27、ゼンツズマブ、その他
インスリン様成長因子IIのタイプ別グローバル売上・予測

・用途別市場分析
用途区分：乳がん、ホルモン感受性乳がん、ハンチントン病、筋ジストロフィー、その他
インスリン様成長因子IIの用途別グローバル売上・予測

・地域別市場分析
地域別インスリン様成長因子II市場規模 2022年と2029年
地域別インスリン様成長因子II売上・予測
北米市場：アメリカ、カナダ、メキシコ
ヨーロッパ市場：ドイツ、フランス、イギリス、イタリア、ロシア
アジア市場：中国、日本、韓国、東南アジア、インド
南米市場：ブラジル、アルゼンチン
中東・アフリカ市場：トルコ、イスラエル、サウジアラビア、UAE

・主要企業の情報（企業概要、事業概要、主要製品、売上、ニュースなど）
Boehringer Ingelheim GmbH、 Genervon Biopharmaceuticals LLC、 MedImmune LLC
...

This report aims to provide a comprehensive presentation of the global market for Insulin Like Growth Factor II, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Insulin Like Growth Factor II. This report contains market size and forecasts of Insulin Like Growth Factor II in global, including the following market information:
Global Insulin Like Growth Factor II Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global Insulin Like Growth Factor II Market Sales, 2018-2023, 2024-2029, (K Pcs)
Global top five Insulin Like Growth Factor II companies in 2022 (%)
The global Insulin Like Growth Factor II market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
Dusigitumab Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Insulin Like Growth Factor II include Boehringer Ingelheim GmbH, Genervon Biopharmaceuticals LLC and MedImmune LLC, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Insulin Like Growth Factor II manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Insulin Like Growth Factor II Market, by Type, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Insulin Like Growth Factor II Market Segment Percentages, by Type, 2022 (%)
Dusigitumab
M-630
GM-6
M-610.27
Xentuzumab
Others
Global Insulin Like Growth Factor II Market, by Application, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Insulin Like Growth Factor II Market Segment Percentages, by Application, 2022 (%)
Breast Cancer
Hormone Sensitive Breast Cancer
Huntington Disease
Muscular Dystrophy
Others
Global Insulin Like Growth Factor II Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions) & (K Pcs)
Global Insulin Like Growth Factor II Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Insulin Like Growth Factor II revenues in global market, 2018-2023 (Estimated), ($ millions)
Key companies Insulin Like Growth Factor II revenues share in global market, 2022 (%)
Key companies Insulin Like Growth Factor II sales in global market, 2018-2023 (Estimated), (K Pcs)
Key companies Insulin Like Growth Factor II sales share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Boehringer Ingelheim GmbH
Genervon Biopharmaceuticals LLC
MedImmune LLC
Outline of Major Chapters:
Chapter 1: Introduces the definition of Insulin Like Growth Factor II, market overview.
Chapter 2: Global Insulin Like Growth Factor II market size in revenue and volume.
Chapter 3: Detailed analysis of Insulin Like Growth Factor II manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Insulin Like Growth Factor II in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Insulin Like Growth Factor II capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.

❖ レポートの目次 ❖

1 Introduction to Research & Analysis Reports
1.1 Insulin Like Growth Factor II Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Insulin Like Growth Factor II Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Insulin Like Growth Factor II Overall Market Size
2.1 Global Insulin Like Growth Factor II Market Size: 2022 VS 2029
2.2 Global Insulin Like Growth Factor II Revenue, Prospects & Forecasts: 2018-2029
2.3 Global Insulin Like Growth Factor II Sales: 2018-2029
3 Company Landscape
3.1 Top Insulin Like Growth Factor II Players in Global Market
3.2 Top Global Insulin Like Growth Factor II Companies Ranked by Revenue
3.3 Global Insulin Like Growth Factor II Revenue by Companies
3.4 Global Insulin Like Growth Factor II Sales by Companies
3.5 Global Insulin Like Growth Factor II Price by Manufacturer (2018-2023)
3.6 Top 3 and Top 5 Insulin Like Growth Factor II Companies in Global Market, by Revenue in 2022
3.7 Global Manufacturers Insulin Like Growth Factor II Product Type
3.8 Tier 1, Tier 2 and Tier 3 Insulin Like Growth Factor II Players in Global Market
3.8.1 List of Global Tier 1 Insulin Like Growth Factor II Companies
3.8.2 List of Global Tier 2 and Tier 3 Insulin Like Growth Factor II Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type – Global Insulin Like Growth Factor II Market Size Markets, 2022 & 2029
4.1.2 Dusigitumab
4.1.3 M-630
4.1.4 GM-6
4.1.5 M-610.27
4.1.6 Xentuzumab
4.1.7 Others
4.2 By Type – Global Insulin Like Growth Factor II Revenue & Forecasts
4.2.1 By Type – Global Insulin Like Growth Factor II Revenue, 2018-2023
4.2.2 By Type – Global Insulin Like Growth Factor II Revenue, 2024-2029
4.2.3 By Type – Global Insulin Like Growth Factor II Revenue Market Share, 2018-2029
4.3 By Type – Global Insulin Like Growth Factor II Sales & Forecasts
4.3.1 By Type – Global Insulin Like Growth Factor II Sales, 2018-2023
4.3.2 By Type – Global Insulin Like Growth Factor II Sales, 2024-2029
4.3.3 By Type – Global Insulin Like Growth Factor II Sales Market Share, 2018-2029
4.4 By Type – Global Insulin Like Growth Factor II Price (Manufacturers Selling Prices), 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application – Global Insulin Like Growth Factor II Market Size, 2022 & 2029
5.1.2 Breast Cancer
5.1.3 Hormone Sensitive Breast Cancer
5.1.4 Huntington Disease
5.1.5 Muscular Dystrophy
5.1.6 Others
5.2 By Application – Global Insulin Like Growth Factor II Revenue & Forecasts
5.2.1 By Application – Global Insulin Like Growth Factor II Revenue, 2018-2023
5.2.2 By Application – Global Insulin Like Growth Factor II Revenue, 2024-2029
5.2.3 By Application – Global Insulin Like Growth Factor II Revenue Market Share, 2018-2029
5.3 By Application – Global Insulin Like Growth Factor II Sales & Forecasts
5.3.1 By Application – Global Insulin Like Growth Factor II Sales, 2018-2023
5.3.2 By Application – Global Insulin Like Growth Factor II Sales, 2024-2029
5.3.3 By Application – Global Insulin Like Growth Factor II Sales Market Share, 2018-2029
5.4 By Application – Global Insulin Like Growth Factor II Price (Manufacturers Selling Prices), 2018-2029
6 Sights by Region
6.1 By Region – Global Insulin Like Growth Factor II Market Size, 2022 & 2029
6.2 By Region – Global Insulin Like Growth Factor II Revenue & Forecasts
6.2.1 By Region – Global Insulin Like Growth Factor II Revenue, 2018-2023
6.2.2 By Region – Global Insulin Like Growth Factor II Revenue, 2024-2029
6.2.3 By Region – Global Insulin Like Growth Factor II Revenue Market Share, 2018-2029
6.3 By Region – Global Insulin Like Growth Factor II Sales & Forecasts
6.3.1 By Region – Global Insulin Like Growth Factor II Sales, 2018-2023
6.3.2 By Region – Global Insulin Like Growth Factor II Sales, 2024-2029
6.3.3 By Region – Global Insulin Like Growth Factor II Sales Market Share, 2018-2029
6.4 North America
6.4.1 By Country – North America Insulin Like Growth Factor II Revenue, 2018-2029
6.4.2 By Country – North America Insulin Like Growth Factor II Sales, 2018-2029
6.4.3 US Insulin Like Growth Factor II Market Size, 2018-2029
6.4.4 Canada Insulin Like Growth Factor II Market Size, 2018-2029
6.4.5 Mexico Insulin Like Growth Factor II Market Size, 2018-2029
6.5 Europe
6.5.1 By Country – Europe Insulin Like Growth Factor II Revenue, 2018-2029
6.5.2 By Country – Europe Insulin Like Growth Factor II Sales, 2018-2029
6.5.3 Germany Insulin Like Growth Factor II Market Size, 2018-2029
6.5.4 France Insulin Like Growth Factor II Market Size, 2018-2029
6.5.5 U.K. Insulin Like Growth Factor II Market Size, 2018-2029
6.5.6 Italy Insulin Like Growth Factor II Market Size, 2018-2029
6.5.7 Russia Insulin Like Growth Factor II Market Size, 2018-2029
6.5.8 Nordic Countries Insulin Like Growth Factor II Market Size, 2018-2029
6.5.9 Benelux Insulin Like Growth Factor II Market Size, 2018-2029
6.6 Asia
6.6.1 By Region – Asia Insulin Like Growth Factor II Revenue, 2018-2029
6.6.2 By Region – Asia Insulin Like Growth Factor II Sales, 2018-2029
6.6.3 China Insulin Like Growth Factor II Market Size, 2018-2029
6.6.4 Japan Insulin Like Growth Factor II Market Size, 2018-2029
6.6.5 South Korea Insulin Like Growth Factor II Market Size, 2018-2029
6.6.6 Southeast Asia Insulin Like Growth Factor II Market Size, 2018-2029
6.6.7 India Insulin Like Growth Factor II Market Size, 2018-2029
6.7 South America
6.7.1 By Country – South America Insulin Like Growth Factor II Revenue, 2018-2029
6.7.2 By Country – South America Insulin Like Growth Factor II Sales, 2018-2029
6.7.3 Brazil Insulin Like Growth Factor II Market Size, 2018-2029
6.7.4 Argentina Insulin Like Growth Factor II Market Size, 2018-2029
6.8 Middle East & Africa
6.8.1 By Country – Middle East & Africa Insulin Like Growth Factor II Revenue, 2018-2029
6.8.2 By Country – Middle East & Africa Insulin Like Growth Factor II Sales, 2018-2029
6.8.3 Turkey Insulin Like Growth Factor II Market Size, 2018-2029
6.8.4 Israel Insulin Like Growth Factor II Market Size, 2018-2029
6.8.5 Saudi Arabia Insulin Like Growth Factor II Market Size, 2018-2029
6.8.6 UAE Insulin Like Growth Factor II Market Size, 2018-2029
7 Manufacturers & Brands Profiles
7.1 Boehringer Ingelheim GmbH
7.1.1 Boehringer Ingelheim GmbH Company Summary
7.1.2 Boehringer Ingelheim GmbH Business Overview
7.1.3 Boehringer Ingelheim GmbH Insulin Like Growth Factor II Major Product Offerings
7.1.4 Boehringer Ingelheim GmbH Insulin Like Growth Factor II Sales and Revenue in Global (2018-2023)
7.1.5 Boehringer Ingelheim GmbH Key News & Latest Developments
7.2 Genervon Biopharmaceuticals LLC
7.2.1 Genervon Biopharmaceuticals LLC Company Summary
7.2.2 Genervon Biopharmaceuticals LLC Business Overview
7.2.3 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor II Major Product Offerings
7.2.4 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor II Sales and Revenue in Global (2018-2023)
7.2.5 Genervon Biopharmaceuticals LLC Key News & Latest Developments
7.3 MedImmune LLC
7.3.1 MedImmune LLC Company Summary
7.3.2 MedImmune LLC Business Overview
7.3.3 MedImmune LLC Insulin Like Growth Factor II Major Product Offerings
7.3.4 MedImmune LLC Insulin Like Growth Factor II Sales and Revenue in Global (2018-2023)
7.3.5 MedImmune LLC Key News & Latest Developments
8 Global Insulin Like Growth Factor II Production Capacity, Analysis
8.1 Global Insulin Like Growth Factor II Production Capacity, 2018-2029
8.2 Insulin Like Growth Factor II Production Capacity of Key Manufacturers in Global Market
8.3 Global Insulin Like Growth Factor II Production by Region
9 Key Market Trends, Opportunity, Drivers and Restraints
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 Insulin Like Growth Factor II Supply Chain Analysis
10.1 Insulin Like Growth Factor II Industry Value Chain
10.2 Insulin Like Growth Factor II Upstream Market
10.3 Insulin Like Growth Factor II Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 Insulin Like Growth Factor II Distributors and Sales Agents in Global
11 Conclusion
12 Appendix
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer

List of Tables
Table 1. Key Players of Insulin Like Growth Factor II in Global Market
Table 2. Top Insulin Like Growth Factor II Players in Global Market, Ranking by Revenue (2022)
Table 3. Global Insulin Like Growth Factor II Revenue by Companies, (US$, Mn), 2018-2023
Table 4. Global Insulin Like Growth Factor II Revenue Share by Companies, 2018-2023
Table 5. Global Insulin Like Growth Factor II Sales by Companies, (K Pcs), 2018-2023
Table 6. Global Insulin Like Growth Factor II Sales Share by Companies, 2018-2023
Table 7. Key Manufacturers Insulin Like Growth Factor II Price (2018-2023) & (USD/Pcs)
Table 8. Global Manufacturers Insulin Like Growth Factor II Product Type
Table 9. List of Global Tier 1 Insulin Like Growth Factor II Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Insulin Like Growth Factor II Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type – Global Insulin Like Growth Factor II Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Global Insulin Like Growth Factor II Revenue (US$, Mn), 2018-2023
Table 13. By Type - Global Insulin Like Growth Factor II Revenue (US$, Mn), 2024-2029
Table 14. By Type - Global Insulin Like Growth Factor II Sales (K Pcs), 2018-2023
Table 15. By Type - Global Insulin Like Growth Factor II Sales (K Pcs), 2024-2029
Table 16. By Application – Global Insulin Like Growth Factor II Revenue, (US$, Mn), 2022 & 2029
Table 17. By Application - Global Insulin Like Growth Factor II Revenue (US$, Mn), 2018-2023
Table 18. By Application - Global Insulin Like Growth Factor II Revenue (US$, Mn), 2024-2029
Table 19. By Application - Global Insulin Like Growth Factor II Sales (K Pcs), 2018-2023
Table 20. By Application - Global Insulin Like Growth Factor II Sales (K Pcs), 2024-2029
Table 21. By Region – Global Insulin Like Growth Factor II Revenue, (US$, Mn), 2022 VS 2029
Table 22. By Region - Global Insulin Like Growth Factor II Revenue (US$, Mn), 2018-2023
Table 23. By Region - Global Insulin Like Growth Factor II Revenue (US$, Mn), 2024-2029
Table 24. By Region - Global Insulin Like Growth Factor II Sales (K Pcs), 2018-2023
Table 25. By Region - Global Insulin Like Growth Factor II Sales (K Pcs), 2024-2029
Table 26. By Country - North America Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2023
Table 27. By Country - North America Insulin Like Growth Factor II Revenue, (US$, Mn), 2024-2029
Table 28. By Country - North America Insulin Like Growth Factor II Sales, (K Pcs), 2018-2023
Table 29. By Country - North America Insulin Like Growth Factor II Sales, (K Pcs), 2024-2029
Table 30. By Country - Europe Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2023
Table 31. By Country - Europe Insulin Like Growth Factor II Revenue, (US$, Mn), 2024-2029
Table 32. By Country - Europe Insulin Like Growth Factor II Sales, (K Pcs), 2018-2023
Table 33. By Country - Europe Insulin Like Growth Factor II Sales, (K Pcs), 2024-2029
Table 34. By Region - Asia Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2023
Table 35. By Region - Asia Insulin Like Growth Factor II Revenue, (US$, Mn), 2024-2029
Table 36. By Region - Asia Insulin Like Growth Factor II Sales, (K Pcs), 2018-2023
Table 37. By Region - Asia Insulin Like Growth Factor II Sales, (K Pcs), 2024-2029
Table 38. By Country - South America Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2023
Table 39. By Country - South America Insulin Like Growth Factor II Revenue, (US$, Mn), 2024-2029
Table 40. By Country - South America Insulin Like Growth Factor II Sales, (K Pcs), 2018-2023
Table 41. By Country - South America Insulin Like Growth Factor II Sales, (K Pcs), 2024-2029
Table 42. By Country - Middle East & Africa Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2023
Table 43. By Country - Middle East & Africa Insulin Like Growth Factor II Revenue, (US$, Mn), 2024-2029
Table 44. By Country - Middle East & Africa Insulin Like Growth Factor II Sales, (K Pcs), 2018-2023
Table 45. By Country - Middle East & Africa Insulin Like Growth Factor II Sales, (K Pcs), 2024-2029
Table 46. Boehringer Ingelheim GmbH Company Summary
Table 47. Boehringer Ingelheim GmbH Insulin Like Growth Factor II Product Offerings
Table 48. Boehringer Ingelheim GmbH Insulin Like Growth Factor II Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 49. Boehringer Ingelheim GmbH Key News & Latest Developments
Table 50. Genervon Biopharmaceuticals LLC Company Summary
Table 51. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor II Product Offerings
Table 52. Genervon Biopharmaceuticals LLC Insulin Like Growth Factor II Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 53. Genervon Biopharmaceuticals LLC Key News & Latest Developments
Table 54. MedImmune LLC Company Summary
Table 55. MedImmune LLC Insulin Like Growth Factor II Product Offerings
Table 56. MedImmune LLC Insulin Like Growth Factor II Sales (K Pcs), Revenue (US$, Mn) and Average Price (USD/Pcs) (2018-2023)
Table 57. MedImmune LLC Key News & Latest Developments
Table 58. Insulin Like Growth Factor II Production Capacity (K Pcs) of Key Manufacturers in Global Market, 2021-2023 (K Pcs)
Table 59. Global Insulin Like Growth Factor II Capacity Market Share of Key Manufacturers, 2021-2023
Table 60. Global Insulin Like Growth Factor II Production by Region, 2018-2023 (K Pcs)
Table 61. Global Insulin Like Growth Factor II Production by Region, 2024-2029 (K Pcs)
Table 62. Insulin Like Growth Factor II Market Opportunities & Trends in Global Market
Table 63. Insulin Like Growth Factor II Market Drivers in Global Market
Table 64. Insulin Like Growth Factor II Market Restraints in Global Market
Table 65. Insulin Like Growth Factor II Raw Materials
Table 66. Insulin Like Growth Factor II Raw Materials Suppliers in Global Market
Table 67. Typical Insulin Like Growth Factor II Downstream
Table 68. Insulin Like Growth Factor II Downstream Clients in Global Market
Table 69. Insulin Like Growth Factor II Distributors and Sales Agents in Global Market
List of Figures
Figure 1. Insulin Like Growth Factor II Segment by Type in 2022
Figure 2. Insulin Like Growth Factor II Segment by Application in 2022
Figure 3. Global Insulin Like Growth Factor II Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Insulin Like Growth Factor II Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Insulin Like Growth Factor II Revenue, 2018-2029 (US$, Mn)
Figure 7. Insulin Like Growth Factor II Sales in Global Market: 2018-2029 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Insulin Like Growth Factor II Revenue in 2022
Figure 9. By Type - Global Insulin Like Growth Factor II Revenue, (US$, Mn), 2022 & 2029
Figure 10. By Type - Global Insulin Like Growth Factor II Revenue Market Share, 2018-2029
Figure 11. By Type - Global Insulin Like Growth Factor II Sales Market Share, 2018-2029
Figure 12. By Type - Global Insulin Like Growth Factor II Price (USD/Pcs), 2018-2029
Figure 13. By Application - Global Insulin Like Growth Factor II Revenue, (US$, Mn), 2022 & 2029
Figure 14. By Application - Global Insulin Like Growth Factor II Revenue Market Share, 2018-2029
Figure 15. By Application - Global Insulin Like Growth Factor II Sales Market Share, 2018-2029
Figure 16. By Application - Global Insulin Like Growth Factor II Price (USD/Pcs), 2018-2029
Figure 17. By Region - Global Insulin Like Growth Factor II Revenue, (US$, Mn), 2022 & 2029
Figure 18. By Region - Global Insulin Like Growth Factor II Revenue Market Share, 2018 VS 2022 VS 2029
Figure 19. By Region - Global Insulin Like Growth Factor II Revenue Market Share, 2018-2029
Figure 20. By Region - Global Insulin Like Growth Factor II Sales Market Share, 2018-2029
Figure 21. By Country - North America Insulin Like Growth Factor II Revenue Market Share, 2018-2029
Figure 22. By Country - North America Insulin Like Growth Factor II Sales Market Share, 2018-2029
Figure 23. US Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 24. Canada Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 25. Mexico Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 26. By Country - Europe Insulin Like Growth Factor II Revenue Market Share, 2018-2029
Figure 27. By Country - Europe Insulin Like Growth Factor II Sales Market Share, 2018-2029
Figure 28. Germany Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 29. France Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 30. U.K. Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 31. Italy Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 32. Russia Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 33. Nordic Countries Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 34. Benelux Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 35. By Region - Asia Insulin Like Growth Factor II Revenue Market Share, 2018-2029
Figure 36. By Region - Asia Insulin Like Growth Factor II Sales Market Share, 2018-2029
Figure 37. China Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 38. Japan Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 39. South Korea Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 40. Southeast Asia Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 41. India Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 42. By Country - South America Insulin Like Growth Factor II Revenue Market Share, 2018-2029
Figure 43. By Country - South America Insulin Like Growth Factor II Sales Market Share, 2018-2029
Figure 44. Brazil Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 45. Argentina Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 46. By Country - Middle East & Africa Insulin Like Growth Factor II Revenue Market Share, 2018-2029
Figure 47. By Country - Middle East & Africa Insulin Like Growth Factor II Sales Market Share, 2018-2029
Figure 48. Turkey Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 49. Israel Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 50. Saudi Arabia Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 51. UAE Insulin Like Growth Factor II Revenue, (US$, Mn), 2018-2029
Figure 52. Global Insulin Like Growth Factor II Production Capacity (K Pcs), 2018-2029
Figure 53. The Percentage of Production Insulin Like Growth Factor II by Region, 2022 VS 2029
Figure 54. Insulin Like Growth Factor II Industry Value Chain
Figure 55. Marketing Channels


❖ 免責事項 ❖
http://www.globalresearch.jp/disclaimer
★リサーチレポート[ インスリン様成長因子IIの世界市場見通し2023年-2029年(Insulin Like Growth Factor II Market, Global Outlook and Forecast 2023-2029)]についてメールでお問い合わせはこちらでお願いします。
◆関連リサーチレポート◆
  • インスリンペンキャップの世界市場見通し2023年-2029年
  • インスリンバイアルの世界市場見通し2023年-2029年
  • ポータブルインスリン冷蔵庫の世界市場見通し2023年-2029年
  • バイオシミラーインスリンの世界市場見通し2023年-2029年
  • ウェアラブルインスリンポンプの世界市場見通し2023年-2029年

    • ◆H&Iグローバルリサーチのお客様（例）◆